In Vitro and in Vivo Combinations of Cefotaxime and Minocycline against Aeromonas hydrophila
Authors:
Open Access
- 1 April 2001
- journal article
- research article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 45 (4) , 1281-1283
Abstract
The activities of cefotaxime and minocycline against Aeromonas hydrophila were investigated. Cefotaxime (4 times the MIC) plus minocycline (0.75 times the MIC) elicited an inhibitory effect for 48 h in a time-kill study, and more infected mice treated with both drugs survived (91%) than survived after treatment with cefotaxime (9%) or minocycline (44%) alone, suggesting that cefotaxime and minocycline act synergistically against A. hydrophila .Keywords
This publication has 14 references indexed in Scilit:
- Clinical Features and Therapeutic Implications of 104 Episodes of Monomicrobial Aeromonas BacteraemiaJournal of Infection, 2000
- Distribution and expression of beta-lactamase genes among Aeromonas sppJournal of Antimicrobial Chemotherapy, 1997
- Aeromonas Bacteremia in Patients with Hematologic Diseases.Internal Medicine, 1997
- Correlation of in-vitro activity and pharmacokinetic parameters with in-vivo effect of amoxycillin, co-amoxiclav and cefotaxime in a murine model of pneumococcal pneumoniaJournal of Antimicrobial Chemotherapy, 1996
- Aeromonas septicaemia in Hong Kong species distribution and associated diseaseJournal of Infection, 1995
- Aeromonas Bacteremia: Review of 59 EpisodesClinical Infectious Diseases, 1995
- Aeromonas Species in Septicemia: Laboratory Characteristics and Clinical ObservationsClinical Infectious Diseases, 1994
- Aeromonas hydrophila Infections of Skin and Soft Tissue: Report of 11 Cases and ReviewClinical Infectious Diseases, 1993
- Inhibition of β-lactamase synthesis in Staphylococcus aureus by minocyclineJournal of Antimicrobial Chemotherapy, 1985
- Comparative Multiple-Dose Pharmacokinetics of Cefotaxime, Moxalactam, and CeftazidimeAntimicrobial Agents and Chemotherapy, 1981